Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre

被引:13
作者
Gnanapragasam, Vincent J. [1 ,2 ]
Thurtle, David [1 ]
Srinivasan, Anandagopal [2 ]
Volanis, Dimitrios [2 ]
George, Anne [1 ]
Lophatananon, Artitaya [3 ]
Stearn, Sara [1 ]
Warren, Anne Y. [4 ]
Lamb, Alastair D. [1 ,2 ]
Shaw, Greg [2 ]
Sharma, Naomi [5 ]
Thomas, Ben C. [2 ]
Tran, Maxine G. [2 ]
Neal, David E. [1 ]
Shah, Nimish C. [2 ]
机构
[1] Univ Cambridge, Dept Surg, Acad Urol Grp, Cambridge, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Dept Urol, Hills Rd, Cambridge CB2 0QQ, England
[3] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry, W Midlands, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Dept Pathol, Cambridge, England
[5] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England
关键词
prostate cancer; robot-assisted laparoscopic prostatectomy; radical prostatectomy; high risk; ISUP CONSENSUS CONFERENCE; INTERNATIONAL-SOCIETY; CANCER; TRENDS; RISK; OVERTREATMENT; RADIOTHERAPY; MANAGEMENT; SURGERY; ENGLAND;
D O I
10.1111/bju.13513
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate the clinical and pathological trends, over a 10-year period, in robot-assisted laparoscopic prostatectomy (RALP) in a UK regional tertiary referral centre. Patients and Methods In all, 1 500 consecutive patients underwent RALP between October 2005 and January 2015. Prospective data were collected on clinicopathological details at presentation as well as surgical outcomes and compared over time. Results The median (range) age of patients throughout the period was 62 (35-78) years. The proportion of preoperative highgrade cases (Gleason score 8-10) rose from 4.6% in 2005-2008 to 18.2% in 2013-2015 (P < 0.001). In the same periods the proportion of clinical stage T3 cases operated on rose from 2.4% to 11.4% (P < 0.001). The median prostate-specific antigen (PSA) level at diagnosis did not alter significantly. Overall, 11.6% of men in 2005-2008 were classified preoperatively as high-risk by National Institute for Health and Care Excellence criteria, compared with 33.6% in 2013-2015 (P < 0.001). The corresponding proportions for low-risk cases were 48.6% and 17.3%, respectively. Final surgical pathology showed an increase in tumour stage, Gleason grade, and nodal status over time. The proportion of pT3 cases rose from 43.2% in 2005-2008 to 55.5% in 2013-2015 (P < 0.001), Gleason score 9-10 tumours increased from 1.8% to 9.1% (P < 0.001) and positive nodal status increased from 1.6% to 12.9% (P < 0.001) between the same periods. Despite this, positive surgical margin rates showed a downward trend in all pT groups across the different eras (P = 0.72). Conclusion This study suggests that the patient profile for RALP in our unit is changing, with increasing proportions of higher stage and more advanced disease being referred and operated on. However, surgical margin outcomes have remained good.
引用
收藏
页码:779 / 784
页数:6
相关论文
共 21 条
[1]  
[Anonymous], 2013, Prostate cancer statistics
[2]   Changes in pathologic outcomes and operative trends with robot-assisted laparoscopic radical prostatectomy [J].
Bernie, Aaron ;
Ramasamy, Ranjith ;
Ali, Adnan ;
Tewari, Ashutosh K. .
INDIAN JOURNAL OF UROLOGY, 2014, 30 (04) :378-382
[3]   The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma [J].
Epstein, JI ;
Allsbrook, WC ;
Amin, MB ;
Egevad, LL ;
Bastacky, S ;
Beltrán, AL ;
Berner, A ;
Billis, A ;
Boccon-Gibod, L ;
Cheng, L ;
Civantos, F ;
Cohen, C ;
Cohen, MB ;
Datta, M ;
Davis, C ;
Delahunt, B ;
Delprado, W ;
Eble, JN ;
Foster, CS ;
Furusato, M ;
Gaudin, PB ;
Grignon, DJ ;
Humphrey, PA ;
Iczkowski, KA ;
Jones, EC ;
Lucia, S ;
McCue, PA ;
Nazeer, T ;
Oliva, E ;
Pan, CC ;
Pizov, G ;
Reuter, V ;
Samaratunga, H ;
Sebo, T ;
Sesterhenn, I ;
Shevchuk, M ;
Srigley, JR ;
Suzigan, S ;
Takahashi, H ;
Tamboli, P ;
Tan, PH ;
Têtu, B ;
Tickoo, S ;
Tomaszewski, JE ;
Troncoso, P ;
Tsuzuki, T ;
True, LD ;
van der Kwast, T ;
Wheeler, TM ;
Wojno, KJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) :1228-1242
[4]   Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006 [J].
Fairley, L. ;
Baker, M. ;
Whiteway, J. ;
Cross, W. ;
Forman, D. .
BRITISH JOURNAL OF CANCER, 2009, 101 (11) :1839-1845
[5]   Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [J].
Ferlay, J. ;
Steliarova-Foucher, E. ;
Lortet-Tieulent, J. ;
Rosso, S. ;
Coebergh, J. W. W. ;
Comber, H. ;
Forman, D. ;
Bray, F. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1374-1403
[6]   RADIOTHERAPY AND SURGERY FOR HIGH-RISK LOCALIZED PROSTATE CANCER: A UK QUESTIONNAIRE SURVEY OF UROLOGISTS AND CLINICAL ONCOLOGISTS [J].
Gnanapragasam, Vincent J. ;
Persad, Raj ;
Payne, Heather A. .
BJU INTERNATIONAL, 2012, 110 (05) :608-612
[7]   The role of surgery in high-risk localised prostate cancer [J].
Gnanapragasam, Vincent J. ;
Mason, Malcolm D. ;
Shaw, Greg L. ;
Neal, David E. .
BJU INTERNATIONAL, 2012, 109 (05) :648-658
[8]   Trends and Outcome from Radical Therapy for Primary Non-Metastatic Prostate Cancer in a UK Population [J].
Greenberg, David C. ;
Lophatananon, Artitaya ;
Wright, Karen A. ;
Muir, Kenneth R. ;
Gnanapragasam, Vincent J. .
PLOS ONE, 2015, 10 (03)
[9]   EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer [J].
Heidenreich, Axel ;
Bastian, Patrick J. ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Joniau, Steven ;
van der Kwast, Theodor ;
Mason, Malcolm ;
Matveev, Vsevolod ;
Wiegel, Thomas ;
Zattoni, Filiberto ;
Mottet, Nicolas .
EUROPEAN UROLOGY, 2014, 65 (02) :467-479
[10]   Changing Trends in Surgical Management of Prostate Cancer: The End of Overtreatment? [J].
Huland, Hartwig ;
Graefen, Markus .
EUROPEAN UROLOGY, 2015, 68 (02) :175-178